General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Siemens(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Kowa(SIGNIFICANT), Roche(MODEST), Vectura(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Agepha(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(NONE), Novo Nordisk Inc.(NONE)

View Full Disclosure